One of Greater Cincinnati’s largest public companies is set to be acquired by a pair of East Asian firms in a deal worth more than $1.5 billion.
Meridian Bioscience (NASDAQ: VIVO), a provider of diagnostic testing and life science raw materials, said Thursday it has entered into agreement to be acquired by South Korea-based SD Biosensor and SJL Partners for $1.53 billion cash.
Click here to read the complete story.
Story excerpt provided by Cincinnati Business Courier.
Written by Liz Engel.
Originally published July 7, 2022.